{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:40:06Z","timestamp":1792435206115,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5K23DA045934"],"award-info":[{"award-number":["5K23DA045934"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-026-09667-0","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:45:55Z","timestamp":1784774755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deviations from the standard of care in the treatment of pregnant people with opioid use disorder in jails; a mixed methods study"],"prefix":"10.1186","volume":"26","author":[{"given":"Sonia","family":"Hamilton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Sommers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Sufrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"9667_CR1","unstructured":"Carson EA, Kluckow R. Prisoners in 2022 \u2013 Statistical Tables. Bur Justice Stat; 2023."},{"key":"9667_CR2","unstructured":"Zeng Z. Jail Inmates in 2022 \u2013 Statistical Tables. Bur Justice Stat. 2022."},{"issue":"5","key":"9667_CR3","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1097\/AOG.0000000000003834","volume":"135","author":"C Sufrin","year":"2020","unstructured":"Sufrin C, Jones RK, Mosher WD, Beal L. Pregnancy Prevalence and Outcomes in U.S. Jails. Obstet Gynecol. 2020;135(5):1177\u201383.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"9667_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/jama.2020.24991","volume":"325","author":"AH Hirai","year":"2021","unstructured":"Hirai AH, Ko JY, Owens PL, Stocks C, Patrick SW. Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010\u20132017. JAMA. 2021;325(2):146\u201355.","journal-title":"JAMA"},{"key":"9667_CR5","doi-asserted-by":"crossref","unstructured":"King Z, Kramer C, Latkin C, Sufrin C. Access to treatment for pregnant incarcerated people with opioid use disorder: Perspectives from community opioid treatment providers. J Subst Abuse Treat. 2021 July 1;126:108338.","DOI":"10.1016\/j.jsat.2021.108338"},{"key":"9667_CR6","unstructured":"Roberts DE. Torn apart: how the child welfare system destroys black families\u2013and how abolition can build a safer world. First edition. New York: Basic Books; 2022. 375 p."},{"key":"9667_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/9781139343244","volume-title":"Policing the womb: invisible women and the criminal costs of motherhood","author":"M Goodwin","year":"2020","unstructured":"Goodwin M. Policing the womb: invisible women and the criminal costs of motherhood. Cambridge, United Kingdom; New York, NY: Cambridge University Press; 2020. p. 1."},{"issue":"11","key":"9667_CR8","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1111\/add.15030","volume":"115","author":"C Sufrin","year":"2020","unstructured":"Sufrin C, Sutherland L, Beal L, Terplan M, Latkin C, Clarke JG. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study. Addict Abingdon Engl. 2020;115(11):2057\u201365.","journal-title":"Addict Abingdon Engl"},{"key":"9667_CR9","doi-asserted-by":"publisher","first-page":"56S","DOI":"10.1097\/01.AOG.0000663364.06637.15","volume":"135","author":"A Mitra","year":"2020","unstructured":"Mitra A, Brandt J, Rosen T, Ananth C, Schuster M. Opioid Use Disorder: A Poorly Understood Cause of Maternal Mortality in the United States [26E]. Obstet Gynecol. 2020;135:56S.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"9667_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ajog.2018.09.028","volume":"220","author":"A Gemmill","year":"2019","unstructured":"Gemmill A, Kiang MV, Alexander MJ. Trends in pregnancy-associated mortality involving opioids in the United States, 2007\u20132016. Am J Obstet Gynecol. 2019;220(1):115\u20136.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"9667_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1056\/NEJMsa064115","volume":"356","author":"IA Binswanger","year":"2007","unstructured":"Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, et al. Release from Prison \u2014 A High Risk of Death for Former Inmates. N Engl J Med. 2007;356(2):157\u201365.","journal-title":"N Engl J Med"},{"issue":"2","key":"9667_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/add.14825","volume":"115","author":"T Nielsen","year":"2020","unstructured":"Nielsen T, Bernson D, Terplan M, Wakeman SE, Yule AM, Mehta PK, et al. Maternal and Infant Characteristics Associated with Maternal Opioid Overdose in the Year Following Delivery. Addiction. 2020;115(2):291\u2013301.","journal-title":"Addiction"},{"key":"9667_CR13","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants. 2018. Available from: https:\/\/store.samhsa.gov\/product\/Clinical-Guidance-for-Treating-Pregnant-and-Parenting-Women-With-Opioid-Use-Disorder-and-Their-Infants\/SMA18-5054. Cited 2023 Oct 19."},{"key":"9667_CR14","unstructured":"Committee on Obstetric Practice, American Society of Addiction Medicine. ACOG Committee Opinion: Opioid Use and Opioid Use Disorder in Pregnancy. The American College of Obstetricians and Gynecologists; 2017. Available from: https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2017\/08\/opioid-use-and-opioid-use-disorder-in-pregnancy. Cited 2023 Oct 19."},{"issue":"5","key":"9667_CR15","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1080\/10550490802266276","volume":"17","author":"HE Jones","year":"2008","unstructured":"Jones HE, O\u2019Grady KE, Malfi D, Tuten M. Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict. 2008;17(5):372\u201386.","journal-title":"Am J Addict"},{"key":"9667_CR16","doi-asserted-by":"crossref","unstructured":"Krans EE, Cochran G, Bogen DL. Caring for Opioid-dependent Pregnant Women: Prenatal and Postpartum Care Considerations. Clin Obstet Gynecol. 2015 June;58(2):370\u20139.","DOI":"10.1097\/GRF.0000000000000098"},{"issue":"5","key":"9667_CR17","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/AOG.0000000000002562","volume":"131","author":"M Terplan","year":"2018","unstructured":"Terplan M, Laird HJ, Hand DJ, Wright TE, Premkumar A, Martin CE, et al. Opioid Detoxification During Pregnancy: A Systematic Review. Obstet Gynecol. 2018;131(5):803\u201314.","journal-title":"Obstet Gynecol"},{"key":"9667_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","volume":"85","author":"JR Morgan","year":"2018","unstructured":"Morgan JR, Schackman BR, Leff JA, Linas BP, Walley AY. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. J Subst Abuse Treat. 2018;85:90\u20136.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"9667_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/AOG.0000000000005115","volume":"141","author":"EA Suarez","year":"2023","unstructured":"Suarez EA, Huybrechts KF, Straub L, Hernandez-Diaz S, Creanga AA, Connery HS, et al. Postpartum Opioid-Related Mortality in Publicly Insured Patients. Obstet Gynecol. 2023;141(4):657\u201365.","journal-title":"Obstet Gynecol"},{"key":"9667_CR20","unstructured":"Substance Abuse and Mental Health Services Administration. Evidence Based, Whole-Person Care for Pregnant People Who Have Opioid Use Disorder. Substance Abuse and Mental Health Services Administration; 2024."},{"issue":"1","key":"9667_CR21","doi-asserted-by":"publisher","first-page":"e2144369","DOI":"10.1001\/jamanetworkopen.2021.44369","volume":"5","author":"C Sufrin","year":"2022","unstructured":"Sufrin C, Kramer CT, Terplan M, Fiscella K, Olson S, Voegtline K, et al. Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails. JAMA Netw Open. 2022;5(1):e2144369.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"9667_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/jchc.22.03.0023","volume":"29","author":"CE Grella","year":"2023","unstructured":"Grella CE, Scott CK, Dennis ML, LaVallee RA. Access to Services for Pregnant People With Opioid Use Disorder in Jails in the United States. J Correct Health Care. 2023;29(4):299\u2013307.","journal-title":"J Correct Health Care"},{"key":"9667_CR23","unstructured":"Maruschak L, Minton T, Zeng Z, Statisticians BJS. Opioid Use Disorder Screening and Treatment in Local Jails, 2019 | Bureau of Justice Statistics. 2019. Available from: https:\/\/bjs.ojp.gov\/library\/publications\/opioid-use-disorder-screening-and-treatment-local-jails-2019. Cited 2024 Aug 3."},{"issue":"6","key":"9667_CR24","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s11606-022-07812-x","volume":"38","author":"C Sufrin","year":"2023","unstructured":"Sufrin C, Kramer C, Terplan M, Fiscella K, Olson S, Voegtline K, et al. Availability of Medications for Opioid Use Disorder in U.S. Jails. J Gen Intern Med. 2023;38(6):1573\u20135.","journal-title":"J Gen Intern Med"},{"key":"9667_CR25","first-page":"100453","volume":"6","author":"C Sufrin","year":"2024","unstructured":"Sufrin C, Ziv T, Dayton L, Latkin C, Kramer C. They talked to me like I was dirt under their feet: Treatment and withdrawal experiences of incarcerated pregnant people with opioid use disorder in four U.S. states. SSM -. Qual Res Health. 2024;6:100453.","journal-title":"Qual Res Health"},{"issue":"1","key":"9667_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40352-021-00137-7","volume":"9","author":"CMA Foudray","year":"2021","unstructured":"Foudray CMA, Kramer C, Rudes DS, Sufrin C, Burr E, Parayil T. The Compendium of U.S. jails: creating and conducting research with the first comprehensive contact database of U.S. jails. Health Justice. 2021;9(1):12.","journal-title":"Health Justice"},{"key":"9667_CR27","doi-asserted-by":"crossref","unstructured":"Edmonds WA, Kennedy TD. Convergent-Parallel Approach. In: An Applied Guide to Research Designs: Quantitative, Qualitative, and Mixed Method. SAGE Publications, Inc; 2017;181\u20138. Available from: https:\/\/methods.sagepub.com\/book\/mono\/an-applied-guide-to-research-designs-2e\/chpt\/convergentparallel-approach. Cited 2024 Aug 3.","DOI":"10.4135\/9781071802779.n15"},{"key":"9667_CR28","unstructured":"Bureau of Justice Assistance, National Institute of Corrections. Guidelines for Managing Substance Withdrawal in Jails: A Tool for Local Government Officials, Jail Administrators, Correctional Officers, and Health Care Professionals. 2023 June. Available from: https:\/\/bja.ojp.gov\/news\/new-resource-guidelines-managing-substance-withdrawal-jails. Cited 2025 June 14."},{"key":"9667_CR29","doi-asserted-by":"publisher","unstructured":"Leech AA, Garbett S, Yu HA, McNeer E, Bharadwaj R, Linas BP et al. Cost-Effectiveness of Treatment for Opioid Use Disorder in Pregnancy and Its Impact on Birth Outcomes. JAMA Pediatr. 2025; Available from: https:\/\/doi.org\/10.1001\/jamapediatrics.2025.3067. Cited 2025 Oct 24.","DOI":"10.1001\/jamapediatrics.2025.3067"},{"key":"9667_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13722-022-00313-6","volume":"17","author":"N Krawczyk","year":"2022","unstructured":"Krawczyk N, Bandara S, Merritt S, Shah H, Duncan A, McEntee B, et al. Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative. Addict Sci Clin Pract. 2022;17:30.","journal-title":"Addict Sci Clin Pract"},{"key":"9667_CR31","doi-asserted-by":"crossref","unstructured":"McNeely HL, Schreiber TL, Swann WL, Amura CR. Facilitators and barriers to adopting or expanding medications for opioid use disorder provision in rural Colorado jails: a qualitative analysis. Health Justice. 2024 June;6:12:26.","DOI":"10.1186\/s40352-024-00280-x"},{"key":"9667_CR32","doi-asserted-by":"crossref","unstructured":"Flanagan Balawajder E, Ducharme L, Taylor BG, Lamuda PA, Kolak M, Friedmann PD et al. Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails. JAMA Netw Open 2024 Sept 24;7(9):e2434704.","DOI":"10.1001\/jamanetworkopen.2024.34704"},{"issue":"1","key":"9667_CR33","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1080\/08897077.2022.2060448","volume":"43","author":"PC Treitler","year":"2022","unstructured":"Treitler PC, Enich M, Reeves D, Crystal S. Medications for opioid use disorder in state prisons: Perspectives of formerly incarcerated persons. Subst Abuse. 2022;43(1):964\u201371.","journal-title":"Subst Abuse"},{"key":"9667_CR34","doi-asserted-by":"crossref","unstructured":"Evans EA, Stopka TJ, Pivovarova E, Murphy SM, Taxman FS, Ferguson WJ, et al. Massachusetts Justice Community Opioid Innovation Network (MassJCOIN). J Subst Abuse Treat. 2021 Sept;1:128:108275.","DOI":"10.1016\/j.jsat.2021.108275"},{"key":"9667_CR35","doi-asserted-by":"publisher","first-page":"109394","DOI":"10.1016\/j.drugalcdep.2022.109394","volume":"234","author":"E Pivovarova","year":"2022","unstructured":"Pivovarova E, Evans EA, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Legislatively mandated implementation of medications for opioid use disorders in jails: A qualitative study of clinical, correctional, and jail administrator perspectives. Drug Alcohol Depend. 2022;234:109394.","journal-title":"Drug Alcohol Depend"},{"key":"9667_CR36","doi-asserted-by":"publisher","first-page":"107514","DOI":"10.1016\/j.drugalcdep.2019.06.016","volume":"205","author":"L Brinkley-Rubinstein","year":"2019","unstructured":"Brinkley-Rubinstein L, Peterson M, Clarke J, Macmadu A, Truong A, Pognon K, et al. The benefits and implementation challenges of the first state-wide comprehensive medication for addictions program in a unified jail and prison setting. Drug Alcohol Depend. 2019;205:107514.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"9667_CR37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/ADM.0000000000000396","volume":"12","author":"N Lintzeris","year":"2018","unstructured":"Lintzeris N, Monds LA, Rivas C, Leung S, Dunlop A, Newcombe D, et al. Transferring Patients From Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines. J Addict Med. 2018;12(3):234\u201340.","journal-title":"J Addict Med"},{"key":"9667_CR38","doi-asserted-by":"crossref","unstructured":"Kaplowitz E, Truong A, Berk J, Martin RA, Clarke JG, Wieck M, et al. Treatment Preference for Opioid Use Disorder Among People who are Incarcerated. J Subst Abuse Treat. 2022 June;137:108690.","DOI":"10.1016\/j.jsat.2021.108690"},{"issue":"1","key":"9667_CR39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/1078345818819855","volume":"25","author":"M Peeler","year":"2019","unstructured":"Peeler M, Fiscella K, Terplan M, Sufrin C. Best Practices for Pregnant Incarcerated Women With Opioid Use Disorder. J Correct Health Care. 2019;25(1):4\u201314.","journal-title":"J Correct Health Care"},{"key":"9667_CR40","unstructured":"CDC, Maternal Mortality P, States. 2020. Available from: https:\/\/www.cdc.gov\/maternal-mortality\/php\/data-research\/index.html."},{"issue":"2","key":"9667_CR41","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1360-0443.2012.03940.x","volume":"108","author":"H Waal","year":"2013","unstructured":"Waal H. Is sustained release naltrexone an option for heroin-dependent pregnant women? - Waal\u2009\u2013\u20092013 - Addiction - Wiley Online Library. Addiction. 2013;108(2):252\u20133.","journal-title":"Addiction"},{"issue":"7678","key":"9667_CR42","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S0140-6736(70)92042-8","volume":"2","author":"TL Wright","year":"1970","unstructured":"Wright TL, Hoffman LH, Davies J. Lithium teratogenicity. Lancet Lond Engl. 1970;2(7678):876.","journal-title":"Lancet Lond Engl"},{"issue":"9","key":"9667_CR43","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","volume":"105","author":"ELC Merrall","year":"2010","unstructured":"Merrall ELC, Kariminia A, Binswanger IA, Hobbs MS, Farrell M, Marsden J, et al. Meta-analysis of drug-related deaths soon after release from prison. Addiction. 2010;105(9):1545\u201354.","journal-title":"Addiction"},{"issue":"9","key":"9667_CR44","doi-asserted-by":"publisher","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","volume":"159","author":"IA Binswanger","year":"2013","unstructured":"Binswanger IA, Blatchford PJ, Mueller SR, Stern MF. Mortality After Prison Release: Opioid Overdose and Other Causes of Death, Risk Factors, and Time Trends From 1999 to 2009. Ann Intern Med. 2013;159(9):592\u2013600.","journal-title":"Ann Intern Med"},{"issue":"2","key":"9667_CR45","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/add.14825","volume":"115","author":"T Nielsen","year":"2020","unstructured":"Nielsen T, Bernson D, Terplan M, Wakeman SE, Yule AM, Mehta PK, et al. Maternal and Infant Characteristics Associated with Maternal Opioid Overdose in the Year Following Delivery. Addict Abingdon Engl. 2020;115(2):291\u2013301.","journal-title":"Addict Abingdon Engl"},{"key":"9667_CR46","unstructured":"Waiver Elimination (MAT Act). 2023. Available from: https:\/\/www.samhsa.gov\/medications-substance-use-disorders\/waiver-elimination-mat-act. Cited 2024 Aug 4."},{"key":"9667_CR47","unstructured":"42 CFR Part 8 Final Rule. 2024. Available from: https:\/\/www.samhsa.gov\/medications-substance-use-disorders\/statutes-regulations-guidelines\/42-cfr-part-8. Cited 2025 Jan 7."}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-09667-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09667-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09667-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:02:55Z","timestamp":1792432975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-09667-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9667"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-09667-0","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Both studies included in this secondary analysis were approved by the Johns Hopkins School of Medicine Institutional Review Board (National Jail Survey: IRB00174954, Qualitative Interviews: IRB00197843). Informed consent to participate was obtained from all of the participants in both studies. These studies adhered to the Declaration of Helsinki regarding research with human subjects.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1185"}}